Cite
HARVARD Citation
Vickers, R. et al. (n.d.). 1344. Ridinilazole (RDZ) for Clostridium difficile Infection (CDI): Impact of Diagnostic Method on Outcomes From a Phase 2 Clinical Trial. Open forum infectious diseases. p. S411. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Vickers, R. et al. (n.d.). 1344. Ridinilazole (RDZ) for Clostridium difficile Infection (CDI): Impact of Diagnostic Method on Outcomes From a Phase 2 Clinical Trial. Open forum infectious diseases. p. S411. [Online].